Background: Previous patterns of energy intake influence gastrointestinal function and appetite, probably reflecting changes in small-intestinal nutrient-mediated feedback. Obese individuals consume more fat and may be less sensitive to its gastrointestinal and appetite-suppressant effects than lean individuals. Objective: To evaluate the hypothesis that, in obese individuals, the effects of duodenal fat on gastrointestinal motor and hormone function, and appetite would be enhanced by a short period on a very-low-calorie diet (VLCD). Methods: Eight obese men (body mass index 34 ± 0.6 kg m À2 ) were studied on two occasions, before (V1), and immediately after (V2), a 4-day VLCD. On both occasions, antropyloroduodenal motility, plasma cholecystokinin (CCK), peptide-YY (PYY) and ghrelin concentrations, and appetite perceptions were measured during a 120-min intraduodenal fat infusion (2.86 kcal min À1 ). Immediately afterwards, energy intake was quantified. Results: During V2, basal pyloric pressure and the number and amplitude of isolated pyloric pressure waves (PWs) were greater, whereas the number of antral and duodenal PWs was less, compared with V1 (all Po0.05). Moreover, during V2, baseline ghrelin concentration was higher; the stimulation of PYY and suppression of ghrelin by lipid were greater, with no difference in CCK concentration; and hunger and energy intake (kJ; V1: 4378 ± 691, V2: 3634 ± 700) were less (all Po0.05), compared with V1. Conclusions: In obese males, the effects of small-intestinal lipid on gastrointestinal motility and some hormone responses and appetite are enhanced after a 4-day VLCD.
Introduction
The prevalence of obesity has assumed enormous proportions; current projections from the World Health Organization indicate that, in 2005, more than 400 million adults were obese worldwide, with numbers forecast to rise up to 700 million by 2015. 1 Current therapeutic interventions for the treatment of obesity are of limited efficacy 2 and, with the exception of bariatric surgery, have largely ignored the pivotal role of the gastrointestinal tract in the regulation of appetite. 3, 4 In health, the interaction of nutrients, including fat, with the small intestine has potent effects on gastrointestinal function. When infused at an energy load of 2-3 kcal min À1 , duodenal lipid slows gastric emptying, associated with suppression of antral and duodenal pressures waves and the stimulation of phasic and tonic pyloric motility, [5] [6] [7] and suppresses appetite and subsequent energy intake. 8, 9 The effects are mediated, at least in part, by the release of a number of gastrointestinal hormones, including cholecystokinin (CCK), glucagon-like peptide-1 and peptide-YY (PYY), and the suppression of ghrelin. [10] [11] [12] [13] Recent evidence suggests that changes in upper gut motility, particularly stimulation of the pylorus, may, per se, affect energy intake.
Studies evaluating gastrointestinal function and appetite in the obese have yielded inconsistent information. A recent study in a large cohort found gastric emptying of both solids and liquids to be accelerated with increasing body weight, 15 whereas others have reported gastric emptying in the obese to be either similar 16 or slower, 17 when compared with lean subjects. The outcome of gut hormone measurements is also inconsistent, for example, some studies have reported lower fasting ghrelin, 15 higher fasting 18 and postprandial 16 plasma CCK, and lower postprandial PYY, 19 glucagon-like peptide-1 20 and ghrelin 21 concentrations, whereas others found no differences in PYY or glucagon-like peptide-1. 15 There is evidence that previous patterns of energy intake, in excess, in restriction and even when sustained for short periods of time, have the capacity to modify gastrointestinal function, 5, [22] [23] [24] and this may be of particular relevance to the inconsistent observations from studies relating to gastrointestinal function in the obese given that previous nutrient intake has not been quantified. For example, in healthy subjects, a 2-week period on a high-fat diet accelerates gastric emptying of a high-fat meal. 5 In contrast, fasting appears to have the opposite effect, so that after a 4-day fast, gastric emptying of glucose is slower in both lean and obese subjects. 22 The nutrient deprivation of critical illness is associated with delayed gastric emptying and increased plasma CCK and PYY concentrations, 23 with evidence that increased small-intestinal feedback contributes to the slowing of gastric emptying. 24 We have now evaluated, in obese subjects, the effects of short-term energy restriction on antropyloroduodenal (APD) motility, plasma CCK, PYY and ghrelin concentrations, and appetite and energy intake, in response to administration of intraduodenal lipid. We hypothesized that acute energy restriction would increase the sensitivity of the small intestine to lipid, resulting in increased stimulation of pyloric pressures, increased stimulation of PYY, but greater suppression of ghrelin, as well as reduced appetite and energy intake.
Subjects and methods

Subjects
Ten obese men (aged 50 ± 1 (range 45-55) years; body mass index 34 ± 0.6 (range 32-36) kg m À2 ) were recruited. One subject failed to adhere to the very-low-calorie diet (VLCD) prescribed and was excluded from the study, and one withdrew for personal reasons; thus, eight subjects completed the study. Based on data derived from a pilot study in four obese subjects (within-subject standard deviation in energy intake: 700 kJ), we calculated that a mean difference in energy intake between visits of 800 kJ would be detectable with a sample size of eight subjects at 80% power and a Bonferroni adjusted significance level of 5%. All subjects were required to be weight-stable, that is, with only o5% fluctuation in their body weight, at study entry, as determined by their weight in the preceding 12 weeks, and were asked to maintain their normal physical activity over the course of the study. Each subject was screened before their inclusion to exclude (i) significant gastrointestinal disease, symptoms or surgery, (ii) diabetes mellitus, (iii) current use of medication known to affect gastrointestinal function, appetite or body weight, (iv) significant cardiovascular or respiratory disease, (v) allergy to local anesthetic, (vi) cigarette smoking, or an alcohol intake in excess of 20 g per day, and (vii) restrained eaters, as assessed by the three-factor eating questionnaire, 25 with a score p12 indicating unrestrained eating. The protocol was approved by the Royal Adelaide Hospital Research Ethics Committee, and the study was registered as a clinical trial (http://www.ANZCTR.org.au/ACTRN12610000083099.aspx), and carried out in accordance with the Declaration of Helsinki. Each subject provided informed, written consent before their enrolment. Subjects were informed that the study would evaluate the effects of short-term energy restriction on gastrointestinal function.
Study design
Each subject attended the laboratory on two occasions, once after an overnight fast (visit 1, day 1) and again after 4 days of a VLCD (visit 2, day 6), with each study commencing at approximately 0830 hours. On both visits, the effects of a 120-min intraduodenal infusion of a lipid emulsion (10% Intralipid, Baxter Healthcare, Old Toongabbie, NSW, Australia), infused at 2.86 kcal min -1 , on APD motility, plasma CCK, PYY and ghrelin concentrations, appetite, and energy intake were quantified.
Very-low-calorie diet
The 4-day VLCD involved a 70% reduction in each individual's energy intake, estimated using the Harris Benedict equation and a physical activity factor between 1.4-1.5 (indicative of light-to-moderate activity) based on an individual's self-reported daily activity. 26 To aid compliance with the VLCD, subjects were provided with individualized meal plans, detailing the food items and their amount (g) to be consumed at each meal, and the food items required for the diet period, including both liquid meal replacements (KicStart, Pharmacy Health Solutions Pty Ltd., Frenchs Forest, New South Wales, Australia) and standard food items (for example, sliced ham, wholemeal bread, salad items, fruit and pre-packaged frozen meals). These were provided to the subjects and ensured a 'balanced' diet complete in micronutrients and protein. Subjects were permitted to consume an unlimited quantity of non-caloric beverages, which they were required to document (including brand names and quantities), together with all the food consumed, throughout the 4 days, in a food diary. Subjects were contacted by phone during day 2 of the 4-day diet to monitor their progress.
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Study protocol for visits 1 and 2
On each study day, subjects attended the laboratory at 0830 hours after fasting from solid and liquid food from 2200 h the previous night. A 16-channel manometric catheter (Dentsleeve International Ltd, Ontario, Canada), to measure pressures in the APD region, was inserted through an anesthetized nostril, allowed to pass through the pylorus into the duodenum by peristalsis and positioned as described earlier, 27 with six side-holes in the antrum (channels 1-6), a 4.5-cm sleeve sensor (channel 7), two sideholes (channels 8 and 9) on the back of the sleeve, across the pylorus, and seven side-holes in the duodenum (channels [10] [11] [12] [13] [14] [15] [16] . The distance between side-holes was 1.5 cm. An intravenous cannula was inserted into an antecubital vein in one arm for blood sampling. Fasting motility was then monitored until the occurrence of phase III of the interdigestive migrating motor complex, after which, and during motor quiescence, a baseline (t ¼ À15 min) blood sample was taken and a validated visual analogue scale questionnaire (VAS), assessing perceptions of appetite, 28 administered. At t ¼ 0 min, intraduodenal infusion of the lipid emulsion commenced and was continued for 120 min. During the infusion, blood samples were obtained and VAS completed every 15 min between t ¼ 0-90 min, and again at t ¼ 120 min. At t ¼ 120 min, subjects were extubated and immediately offered a standardized, cold, buffet-style meal, as described earlier. 3 The amount of food was in excess of what the subject was expected to consume. The total energy content of the meal was 10 600 kJ, with 48.7% energy from carbohydrate, 31.5% from fat and 19.7% from protein. The subject was allowed up to 30 min to consume their meal and instructed to eat until comfortably full. A final blood sample was collected and VAS completed after the meal (t ¼ 150 min), after which the intravenous cannula was removed, and the subject was allowed to leave the laboratory.
Measurements
APD pressures
Manometric pressures were digitized and recorded on a computer-based system and stored for subsequent analysis. APD pressures were analyzed for (i) the number and amplitude of pressure waves (PWs) in the antrum and duodenum, (ii) basal pyloric pressure (pyloric 'tone'), (iii) the number and amplitude of isolated pyloric pressure waves (IPPWs) and (iv) pressure wave sequences (PWSs), as earlier described.
29
Plasma hormone concentrations Venous blood samples (10 ml), for determination of plasma CCK, PYY and ghrelin concentrations, were collected, as described. 8, 30 Plasma CCK (pmol l À1 ), PYY (pg ml À1 ) and ghrelin (pg ml
À1
) concentrations were determined by sensitive and specific radioimmunoassays, as described. [30] [31] [32] All samples were measured in the same run.
Appetite and energy intake
Hunger and fullness were assessed using a validated 100-mm VAS. 28 Nausea and bloating were also quantified. The subject was asked to place a vertical mark along the line to indicate the strength of each sensation. The amount (g) of food consumed from the buffet meal was determined by weighing the meal before and after consumption. Energy intake (kJ) was analyzed using commercially available software (Foodworks 3.01, Xyris Software, Highgate Hill, Queensland, Australia). 3 
Statistical analysis
Baseline values ('0') were calculated as the mean of values obtained at t ¼ À15 and 0 min for plasma hormone concentrations and VAS, and between t ¼ À15 to 0 min for the total number and mean amplitude of antral and duodenal PWs, IPPWs, basal pyloric pressures and total number of PWSs. The number and amplitude of antral and duodenal PWs were expressed as total and mean values, respectively, during the infusion period. IPPWs and basal pyloric pressure were expressed as mean values of 15-min segments between 0-120 min (that is, 0-15, 15-30, y , 105-120 min), and PWSs as mean numbers of waves traveling over defined distances (that is, over two (1.5 to o3 cm), three (3 to o4.5 cm), four (4.5 to o6 cm), y , fifteen (21 to o22.5 cm) channels). For IPPWs and basal pyloric pressures, peak values were also determined by identifying in each individual the peak number and amplitude of IPPWs as well as peak basal pyloric pressure and then calculating mean values. To evaluate temporal differences in the responses during the infusion period, data were divided into two periods, that is, from t ¼ 0 to 60 min and from t ¼ 60 to 120 min. IPPWs, basal pyloric pressures, PWSs, plasma hormones and VAS were analyzed by repeated-measures analysis of variance, with time (for PWSs, distance of propagation) and visit as factors. The number and amplitude of antral and duodenal PWs, and energy intake were analyzed by one-way analysis of variance. Post-hoc paired comparisons, adjusted for multiple comparisons by Bonferroni's correction, were performed when analyses of variance revealed significant effects. Statistical significance was accepted at Po0.05, and data are presented as means±s.e.m.
Results
All subjects completed the study and tolerated the experimental conditions well. The mean score for eating restraint was 5 ± 0.4 (range [3] [4] [5] [6] [7] , that is, all were unrestrained eaters. The average 30% daily energy requirement was 3938 ± 63 kJ. Based on the dietary records maintained by the subjects, 100% compliance with the VLCD was achieved. There was no difference in body weight between visit 1 (102.9 ± 2.4 kg) and visit 2 (100.8 ± 2.2 kg). (Figure 1b) . The peak number of IPPWs was greater on visit 2 (37±3/15 min), when compared with visit 1 (28 ± 2/15 min) (Po0.05). There was an effect of treatment on the number of IPPWs (Po0.05). Between t ¼ 0-60 min, the number of IPPWs was greater during visit 2, when compared with visit 1 (Po0.05), whereas there was no difference between t ¼ 60-120 min, although mean values were higher during visit 2.
In response to lipid, the amplitude of IPPWs rose until t ¼ 45 min during visit 1, and until t ¼ 30 min during visit 2 (time effect: Po0.01 for both); the responses then declined gradually (Figure 1c) . The peak amplitude of IPPWs was greater on visit 2 (63 ± 7 mm Hg), when compared with visit 1 (51±6 mm Hg) (Po0.05). There was an effect of treatment on the amplitude of IPPWs (Po0.01). Between t ¼ 0-60 min, the amplitude of IPPWs was higher during visit 2, when compared with visit 1 (Po0.05), while there was no difference between t ¼ 60-120 min, although mean values were higher during visit 2.
Duodenal pressures.
There was an effect of treatment on the number (Po0.05), but not the amplitude, of duodenal PWs ( Table 1 ). The number was less on visit 2 (by B36%), when compared with visit 1. Energy restriction, gut function and appetite IM Brennan et al Pressure wave sequences. Only PWSs that spanned 2-6 channels (1.5-9 cm) were analyzed statistically, as PWSs spanning 7-15 channels were infrequent (no./120 min: visit 1, 6±1; visit 2, 2±1). There was an effect of treatment on the number of PWSs traveling over two (that is, 1.5o3 cm), three (that is, 3o4.5 cm), four (that is, 4.5o6 cm) and five (that is, 6o7.5 cm) (Po0.05 for all) channels, which were substantially less on visit 2 when compared with visit 1 (Figure 2 ).
Gastrointestinal hormone concentrations Plasma CCK. There was no difference in CCK concentrations at baseline, or in response to lipid, between visit 1 and visit 2 ( Figure 3a) . During both visits, plasma CCK concentrations increased in response to lipid until t ¼ 30 min (time effect: Po0.001 for both), after which levels decreased and then plateaued. Immediately after the buffet meal (that is, t ¼ 150 min), plasma CCK concentrations were lower on both visit 1 and visit 2 (Po0.05 for both), when compared with premeal concentrations (that is, t ¼ 120 min), with no difference between visits.
Plasma PYY. There was no difference in baseline PYY concentrations between visit 1 and visit 2 ( Figure 3b ). There was a treatment-by-time interaction for plasma PYY concentrations (Po0.05). During both visits, plasma PYY concentrations increased in response to lipid across the entire infusion period (time effect: Po0.01 for both). The magnitude of the rise was greater during visit 2, so that plasma PYY was higher between t ¼ 90-120 min, when compared with visit 1 (Po0.05). Immediately after the buffet meal, there was no difference in plasma PYY, when compared with premeal concentrations, during either visit 1 or visit 2.
Plasma ghrelin. There was an effect of treatment on baseline ghrelin concentrations (Po0.001), which were higher on visit 2 when compared with visit 1 (Figure 3c ). There was a treatment-by-time interaction for plasma ghrelin concentrations (Po0.001). During visit 1, plasma ghrelin decreased, albeit very slightly, between t ¼ 30-120 min, whereas during visit 2, plasma ghrelin decreased steadily across the entire infusion period (time effect: Po0.05). The magnitude of the decrease was greater during visit 2, so that plasma ghrelin was Energy restriction, gut function and appetite IM Brennan et al higher between t ¼ 0-60 min (Po0.05), when compared with visit 1, but there was no difference between visits immediately before the buffet meal. Immediately after the buffet meal, there was no difference in plasma ghrelin, when compared with premeal concentrations, during either visit 1 or visit 2.
Gastrointestinal perceptions
There was an effect of treatment on baseline scores for hunger (Po0.001), which were higher on visit 2 when compared with visit 1 (Figure 4a ). There was a treatmentby-time interaction for hunger (Po0.001). During visit 1, hunger increased slightly, whereas during visit 2, hunger declined gradually during the entire infusion period (time effect: Po0.05). Hunger was greater during visit 2 between t ¼ 0-60 min (Po0.05), when compared with visit 1, but there was no difference between visits between t ¼ 75-120 min. There were no differences in scores for fullness, bloating (data not shown) or nausea (Figure 4b ) between visits.
Energy intake
There was an effect of treatment on both the amount eaten (g) and energy intake (kJ) at the buffet meal (Po0.05 for both) ( Table 2 ). Both were less on visit 2 when compared with visit 1, by 8% and 17%, respectively.
Discussion
This study has evaluated the effects of a 4-day VLCD on APD motor, gastrointestinal hormone, appetite and energy intake responses to an intraduodenal lipid infusion in obese males. Arguably, the most important, and novel, finding of our study is that, within the short period of 4 days, a VLCD increases the 'sensitivity' to small-intestinal fat in obese individuals, associated with enhanced modulation of gastrointestinal motor and hormone function and potentiation of the suppression of hunger and energy intake.
A number of modifications in gastrointestinal function have been described in the obese, 15, 16, 18, 19, 33 which may potentially be attributable to gastrointestinal adaptation to high nutrient exposure. Whether such changes are reversible in response to energy restriction has not been investigated in detail, but is conceivable. That a 4-day fast slowed gastric emptying of glucose in both lean and obese subjects 22 suggests that acute dietary restriction is associated with adaptive changes in the mechanisms responsible for the feedback slowing of gastric emptying. Our data relating to gastrointestinal motility support this hypothesis. Following acute energy restriction, the stimulation of tonic and phasic pyloric pressures and the suppression of antral and duodenal pressures by small-intestinal lipid were markedly greater. These motor events underlie the slowing of gastric emptying induced by small-intestinal lipid, 27 consistent with the reported slowing of gastric emptying following a 4-day fast. 22 Moreover, our recent study 14 identified the magnitude of peak pyloric stimulation in response to duodenal nutrients as an independent predictor of subsequent energy intake. PYY and ghrelin, but not CCK, responses were modified following acute dietary restriction. Although baseline PYY concentrations were unchanged, its release in response to the lipid infusion was increased following the 4-day fast. Energy restriction, gut function and appetite IM Brennan et al PYY is released from the distal small intestine, indirectly by CCK 34 or directly by the interaction of nutrients with PYYreleasing L-cells in the distal small intestine. 35 As CCK concentrations were unchanged, it would suggest either that CCK was not involved in enhancing PYY release or that the sensitivity to the actions of CCK was enhanced, following the 4-day diet. The difference in PYY concentrations between the two study days was evident between 90-120 min, that is, at a time when some lipid would almost certainly have reached the distal small intestine. In this context, it is interesting to note that, after the 4-day diet, the number of PW sequences in response to lipid was less, suggesting that small-intestinal transit, which we did not measure, was likely to be slowed, potentially as an effect of elevated PYY. 36 Interestingly, despite this, PYY release was enhanced, supporting the hypothesis that the sensitivity of the small intestine to nutrients was enhanced by the dietary intervention. Plasma ghrelin concentrations are high in the fasting state and suppressed following meal ingestion, 21 or direct small-intestinal lipid infusion, 37 with the latter suggesting that ghrelin suppression arises from the small intestine. In obesity, fasting ghrelin concentrations have been reported to be reduced, and postprandial suppression may 33 or may not 38 be absent. In our study, lipid-induced ghrelin suppression before the 4-day diet was minimal. In contrast, both fasting ghrelin concentrations and the magnitude of suppression during the lipid infusion were greater after the 4-diet diet, suggesting that even a short period of dietary restriction can modulate ghrelin release towards normality. Not unexpectedly, the higher fasting ghrelin concentrations were associated with increased hunger scores, and both fell in parallel during the lipid infusion to levels not different from those before the VLCD. Taken together, it appears that of absolute plasma hormone concentrations, only PYY can be implicated in the observed reduction in energy intake. The mechanisms that mediate the gastrointestinal and appetite responses to a VLCD are unknown. Studies in rats have demonstrated that both myenteric neuronal and vagal afferent activation, as measured by Fos-like immunoreactivity in the dorsal hindbrain and the myenteric plexus, in response to small intestinal oleate, are diminished after a period on a high-fat diet, compared with an isocaloric low-fat diet. 39 Furthermore, the high-fat diet reduced the expression of Fos-like immunoreactivity in the area postrema and the nucleus of the solitary tract in response to exogenous CCK, 40 suggesting that, in response to a high-fat diet, adaptations occur in the transmission processes involved in conveying luminal signals to the brain, associated with a reduced sensitivity to small intestinal nutrients. Thus, it is likely that changes in the opposite direction occur in response to dietary restriction. The focus of our study was to determine whether acute dietary restriction can modify gastrointestinal functions associated with energy intake reduction. If these changes were to be sustained over a prolonged period of time, substantial weight loss would be expected. However, it is also possible that, during a longer period of energy restriction, adaptive mechanisms develop, which aim to preserve energy stores. For example, resting energy expenditure is reduced with weight loss, even after adjustment for loss of lean and fat mass. 41 Whether adaptive changes in gastrointestinal function occur during prolonged weight loss periods accordingly warrants evaluation. In interpreting our data, it is important to consider the experimental design of the study. We administered the lipid emulsion directly into the duodenum, as our primary focus was to identify potential changes in small intestinal sensitivity to lipid. As a result, we bypassed potential gustatory and gastric mechanisms and cannot comment on any effect(s) on gastric emptying. These issues should be addressed in subsequent studies. Only one dose of intraduodenal lipid, one type of caloric restriction and one period of dietary restriction were employed. Hence, the effects of higher, or lower, lipid loads, other macronutrients, and other degrees of energy restriction and duration are uncertain. The order of the study days was not randomized; however, we have demonstrated that our test meal used to evaluate energy intake does so reliably when administered repeatedly under identical study conditions, 42 and the observed differences in the current study were substantial. Only male volunteers were included to avoid any confounding effects of the menstrual cycle 43 and, accordingly, our observations may not be applicable to females, albeit unlikely. Finally, our study did not include a control arm to exclude the possibility that the observed effects may reflect habituation to the test procedures or a time effect. However, this is highly unlikely given that the parameters measured have been shown to be highly reproducible in the short term in healthy subjects, 42 the differences in the responses between study days were substantial and comparable in magnitude to the responses observed in our previous studies comparing the effects of intraduodenal nutrients with control infusions, 32 and a previous study showed that short-term (4-day) starvation in obese subjects had no effect on gastric emptying of saline, whereas gastric emptying of glucose was slowed substantially. 22 
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